P

Inventor

CARAVELLA JUSTIN A

US11 patents
⚠️ This page may combine multiple inventors who share the name “CARAVELLA JUSTIN A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FORMA THERAPEUTICS INC

5 patents
US9902728B2Feb 27, 2018

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC24 citations93
US11161848B2Nov 2, 2021

Purinones as ubiquitin-specific protease 1 inhibitors

FORMA THERAPEUTICS INC1 citations73
US10399980B2Sep 3, 2019

Purinones as ubiquitin-specific protease 1 inhibitors

FORMA THERAPEUTICS INC2 citations73
US10189841B2Jan 29, 2019

Purinones as ubiquitin-specific protease 1 inhibitors

FORMA THERAPEUTICS INC3 citations73
US10913753B2Feb 9, 2021

Thienopyridine carboxamides as ubiquitin-specific protease inhibitors

FORMA THERAPEUTICS INC2 citations61

VALO HEALTH INC

2 patents
US11325917B2May 10, 2022

Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors

VALO HEALTH INC0 citations62
US12252490B2Mar 18, 2025

Inhibiting deubiquitinase USP25 and USP28

VALO HEALTH INC0 citations59

VALO EARLY DISCOVERY INC

1 patent
US10889592B2Jan 12, 2021

Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors

VALO EARLY DISCOVERY INC2 citations71

TAYLOR FREDERICK R

1 patent
US9738707B2Aug 22, 2017

Heterodimeric Fc regions, binding molecules comprising same, and methods relating thereto

TAYLOR FREDERICK R2 citations70

BIOGEN MA INC

1 patent
US9902775B2Feb 27, 2018

Anti-blood dendritic cell antigen 2 antibodies and uses thereof

BIOGEN MA INC6 citations66

CAMP4 THERAPEUTICS CORP

1 patent
US12319916B2Jun 3, 2025

Modulation of gene transcription using antisense oligonucleotides targeting regulatory RNAs

CAMP4 THERAPEUTICS CORP0 citations50